Kauffman Fellows’ Post

Calm/Storm continues to make waves in the HealthTech and FemTech investment space! Recognized as Europe's most active early-stage HealthTech investor for the third consecutive year by Financial Times and Sifted, Calm/Storm is shaping the future of digital health innovation. The firm closed 33 deals in 2024 alone (10 new, 23 follow-on), showcasing its commitment to driving impactful healthcare solutions. Additionally, PitchBook has named Calm/Storm as one of the world's top 10 most active FemTech investors. With 11 FemTech investments since 2020, Calm/Storm is a European leader in advancing women's health innovation, focusing on fertility, intimate health, and AI-powered healthcare. Notable 2024 investments include: -Béa Fertility (UK): Revolutionizing fertility treatments. -Meela (Sweden): A platform for therapist bookings. -Univa (UK): Developing digital care tools for eating disorders. Operating out of Vienna, Calm/Storm is investing from its second fund, having exceeded its €20M target and aiming for a final close of €40M in Q1 2025. With a ticket size of €250k–1M, the firm is empowering startups to bridge the gender health gap. Congratulations to Lucanus ⛵️ Polagnoli (KF Class 27) and Ekaterina Gianelli (KF Class 25) for driving change in health innovation! #VentureCapital #HealthTech #FemTech #KauffmanFellows

Impressive achievements by Calm/Storm! For those interested in learning more about these awards and recognitions: Financial Times/Sifted: https://sifted.eu/articles/europe-healthtech-investor-funding Trending Topics: https://www.trendingtopics.eu/vienna-vc-calm-storm-among-the-top-10-most-active-femtech-investors-worldwide/ Excited to see the continued impact in HealthTech and FemTech innovation! 🚀

To view or add a comment, sign in

Explore topics